Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy.
Jose S, Quinn K, Hill T, Leen C, Walsh J, Hay P, Fisher M, Post F, Nelson M, Gompels M, Johnson M, Chadwick D, Gilson R, Sabin C, Fidler S; UK CHIC Steering Committee.
Jose S, et al. Among authors: sabin c.
AIDS. 2014 Jun 1;28(9):1333-9. doi: 10.1097/QAD.0000000000000242.
AIDS. 2014.
PMID: 24583670
Free PMC article.